EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS

Several severe complications may be associated with the use of central venous catheters (CVC). We retrospectively evaluated on a large cohort of patients the incidence of CVC-related early and late complications. From 7/99 to 12/2005, 1102 CVC have been implanted at our Institution in 881 patients w...

Full description

Saved in:
Bibliographic Details
Main Authors: Salvatore Giacomo Morano, Lorenzo Coppola, Roberto Latagliata, Paola Berneschi, Antonio Chistolini, Alessandra Micozzi, Corrado Girmenia, Massimo Breccia, Gregorio Brunetti, Angela Matturro, Giovanni Rosa, Pietro Guerrisi, Franco Mandelli, Roberto Foà, Giuliana Alimena
Format: Article
Language:English
Published: PAGEPress Publications 2014-02-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/1383
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850088421305876480
author Salvatore Giacomo Morano
Lorenzo Coppola
Roberto Latagliata
Paola Berneschi
Antonio Chistolini
Alessandra Micozzi
Corrado Girmenia
Massimo Breccia
Gregorio Brunetti
Angela Matturro
Giovanni Rosa
Pietro Guerrisi
Franco Mandelli
Roberto Foà
Giuliana Alimena
author_facet Salvatore Giacomo Morano
Lorenzo Coppola
Roberto Latagliata
Paola Berneschi
Antonio Chistolini
Alessandra Micozzi
Corrado Girmenia
Massimo Breccia
Gregorio Brunetti
Angela Matturro
Giovanni Rosa
Pietro Guerrisi
Franco Mandelli
Roberto Foà
Giuliana Alimena
author_sort Salvatore Giacomo Morano
collection DOAJ
description Several severe complications may be associated with the use of central venous catheters (CVC). We retrospectively evaluated on a large cohort of patients the incidence of CVC-related early and late complications. From 7/99 to 12/2005, 1102 CVC have been implanted at our Institution in 881 patients with haematological malignancies (142,202 total day number of implanted CVC). Early mechanic complications were 79 (7.2% - 0.55/1,000 days/CVC). Thirty-nine episodes of early infective complications (<1 week from CVC implant) occurred (3.5% - 0.3/1000 days/CVC): furthermore, 187 episodes of CVC-related sepsis (17% - 1.3/1000 days/CVC) were recorded. There were 29 episodes (2.6%) of symptomatic CVC-related thrombotic complications, with a median interval from CVC implant of 60 days (range 7 – 395). The rate of CVC withdrawal due to CVC-related complications was 26%. The incidence of CVC-related complications in our series is in the range reported in the literature, notwithstanding cytopenia often coexisting in haematological patients.
format Article
id doaj-art-792d87dc587d41ccb188e7b27ac9e53b
institution DOAJ
issn 2035-3006
language English
publishDate 2014-02-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-792d87dc587d41ccb188e7b27ac9e53b2025-08-20T02:43:00ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062014-02-0161e2014011e201401110.4084/mjhid.2014.0111143EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTSSalvatore Giacomo Morano0Lorenzo Coppola1Roberto Latagliata2Paola Berneschi3Antonio Chistolini4Alessandra Micozzi5Corrado Girmenia6Massimo Breccia7Gregorio Brunetti8Angela Matturro9Giovanni Rosa10Pietro Guerrisi11Franco Mandelli12Roberto Foà13Giuliana Alimena14Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Hematology “AOU” Sassari, ItalyDepartment of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Dipartimento Anestesia e Rianimazione, Azienda Policlinico Umberto I, "Sapienza" Università di RomaDipartimento Scienze Radiologiche, Azienda Policlinico Umberto I, "Sapienza" Università di RomaDepartment of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)Several severe complications may be associated with the use of central venous catheters (CVC). We retrospectively evaluated on a large cohort of patients the incidence of CVC-related early and late complications. From 7/99 to 12/2005, 1102 CVC have been implanted at our Institution in 881 patients with haematological malignancies (142,202 total day number of implanted CVC). Early mechanic complications were 79 (7.2% - 0.55/1,000 days/CVC). Thirty-nine episodes of early infective complications (<1 week from CVC implant) occurred (3.5% - 0.3/1000 days/CVC): furthermore, 187 episodes of CVC-related sepsis (17% - 1.3/1000 days/CVC) were recorded. There were 29 episodes (2.6%) of symptomatic CVC-related thrombotic complications, with a median interval from CVC implant of 60 days (range 7 – 395). The rate of CVC withdrawal due to CVC-related complications was 26%. The incidence of CVC-related complications in our series is in the range reported in the literature, notwithstanding cytopenia often coexisting in haematological patients.http://www.mjhid.org/index.php/mjhid/article/view/1383CVC, haematological malignancies, infections, thrombosis, cytopenia
spellingShingle Salvatore Giacomo Morano
Lorenzo Coppola
Roberto Latagliata
Paola Berneschi
Antonio Chistolini
Alessandra Micozzi
Corrado Girmenia
Massimo Breccia
Gregorio Brunetti
Angela Matturro
Giovanni Rosa
Pietro Guerrisi
Franco Mandelli
Roberto Foà
Giuliana Alimena
EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS
Mediterranean Journal of Hematology and Infectious Diseases
CVC, haematological malignancies, infections, thrombosis, cytopenia
title EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS
title_full EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS
title_fullStr EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS
title_full_unstemmed EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS
title_short EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS
title_sort early and late complications related to central venous catheters in haematological malignancies a retrospective analysis of 1102 patients
topic CVC, haematological malignancies, infections, thrombosis, cytopenia
url http://www.mjhid.org/index.php/mjhid/article/view/1383
work_keys_str_mv AT salvatoregiacomomorano earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT lorenzocoppola earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT robertolatagliata earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT paolaberneschi earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT antoniochistolini earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT alessandramicozzi earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT corradogirmenia earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT massimobreccia earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT gregoriobrunetti earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT angelamatturro earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT giovannirosa earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT pietroguerrisi earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT francomandelli earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT robertofoa earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients
AT giulianaalimena earlyandlatecomplicationsrelatedtocentralvenouscathetersinhaematologicalmalignanciesaretrospectiveanalysisof1102patients